TABLE 20

Risk-adjusted multivariable marginal model for all-cause mortality at 28 days

Risk factorORa (95% CI)p-value
Glasgow Coma Scale score (per one-unit increase)0.80 (0.77 to 0.84)< 0.0001
ISS score (per one-unit increase)1.03 (1.02 to 1.04)< 0.0001
Participant age (spline term)See Figure 9< 0.0001
Systolic blood pressure (spline term)See Figure 10< 0.0001
Intervention armb1.15 (0.93 to 1.42)0.1984
a

Adjusted OR from logistic regression model, also adjusted for centre.

b

Treatment arm was not statistically significant in the model, but the treatment effect adjusted for the factors above is presented.

Image 15-57-02_fig9
Image 15-57-02_fig10

From: Appendix 2, Additional tables and figures

Cover of Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis
Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis.
Health Technology Assessment, No. 28.76.
Curry N, Davenport R, Thomas H, et al.
Copyright © 2024 Curry et al.

This work was produced by Curry et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.